Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

Clinical Research Site, The Bronx

Clinical Research Site, Williamsville

Clinical Research Site, Philadelphia

Clinical Research Site, McLean

Clinical Research Site, Charlottesville

Clinical Research Site, Charleston

Clinical Research Site, Stockbridge

Clinical Research Site, Ormond Beach

Clinical Research Site, Pensacola

Clinical Research Site, DeLand

Clinical Research Site, Oviedo

Clinical Research Site, Winter Park

Clinical Research Site, Hallandale

Clinical Research Site, Hollywood

Clinical Research Site, Miami

Clinical Research Site, Nashville

Clinical Research Site, Knoxville

Clinical Research Site, Avon

Clinical Research Site, Cypress

Clinical Research Site, Sugar Land

Clinical Research Site, Salt Lake City

Clinical Research Site, Albuquerque

Clinical Research Site, Las Vegas

Clinical Research Site, Los Angeles

Clinical Research Site, Sherman Oaks

Clinical Research Site, La Jolla

Clinical Research Site, Colton

Clinical Research Site, Fullerton

Clinical Research Site, Stamford

Clinical Research Site, Boston

Clinical Research Site, North Dartmouth